Rosuvastatin protects against coronary microembolization-induced cardiac injury via inhibiting NLRP3 inflammasome-dependent pyroptosis

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Thrombosis and Inflammation in Acute Coronary Syndrome: Insights from Translational Research Inflammation ESC Premium Access ESC Congress 2020

ESC 365 is supported by

ESC 365 is supported by